BDRX Articles, Biodexa Pharmaceuticals PLC-ADR - From 03/28/24

U.S. stocks traded mixed this morning, with the Dow Jones index trading almost flat on Thursday. Following the market opening Thursday, the Dow tra...

Friday, Biodexa Pharmaceuticals PLC (NASDAQ:BDRX) announced an R&D update, including topline clinical trial results of a recently com...

Shares of IPG Photonics Corporation (NASDAQ: IPGP) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter fin...

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) shares are trading higher after the company filed an SEC Schedule 13G filing on Monday. Th...

Biodexa Pharmaceuticals PLC Biodexa Announces Allowance of U.S. Patent Covering Tolimidone Biodexa plans to initiate a Phase 2 clinical program of...

Biodexa Pharmaceuticals PLC("Biodexa" or the "Company") Biodexa Appoints Ann Merchant to the Board of Directors CARDIFF, United Kingdom, Dec. 29, ...

Over the past twenty days of trading, Biodexa Pharmaceuticals PLC-ADR (NASDAQ: BDRX), from November 21, 2023 to December 19, 2023 there is a poten...

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 200 points on Tuesday. The Dow traded up 0.53% to 37,5...

Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to ...

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 150 points on Tuesday. The Dow traded up 0.46% to 37,476.21 whil...